NCT02826564View on ClinicalTrials.gov

Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

April 2, 2018

Study Completion Date

February 18, 2019

Conditions
Metastatic Urothelial Cancer
Interventions
DRUG

pembrolizumab

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT02826564 - Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer | Biotech Hunter | Biotech Hunter